These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3023204)

  • 1. Poor prognosis metastatic gestational trophoblastic disease: experience with moderate dose methotrexate plus folinic acid rescue as initial therapy.
    Gerulath AH; Dembo AJ; Aitken S; Quirt IC; Osborne R; Blackstein M; Rider WD
    Gynecol Oncol; 1986 Nov; 25(3):294-301. PubMed ID: 3023204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High risk malignant gestational trophoblastic disease: experience with triple chemotherapy (MAC) in Third World circumstances.
    du Toit JP
    Gynecol Oncol; 1989 Mar; 32(3):310-3. PubMed ID: 2465940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective randomized comparison of methotrexate, dactinomycin, and chlorambucil versus methotrexate, dactinomycin, cyclophosphamide, doxorubicin, melphalan, hydroxyurea, and vincristine in "poor prognosis" metastatic gestational trophoblastic disease: a Gynecologic Oncology Group study.
    Curry SL; Blessing JA; DiSaia PJ; Soper JT; Twiggs LB
    Obstet Gynecol; 1989 Mar; 73(3 Pt 1):357-62. PubMed ID: 2536911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-risk persistent gestational trophoblastic disease: outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000.
    McNeish IA; Strickland S; Holden L; Rustin GJ; Foskett M; Seckl MJ; Newlands ES
    J Clin Oncol; 2002 Apr; 20(7):1838-44. PubMed ID: 11919242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Poor prognosis" metastatic gestational trophoblastic disease: the prognostic significance of the scoring system in predicting chemotherapy failures.
    Mortakis AE; Braga CA
    Obstet Gynecol; 1990 Aug; 76(2):272-7. PubMed ID: 2164651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose methotrexate for gestational trophoblastic disease.
    Elit L; Covens A; Osborne R; Gerulath A; Murphy J; Rosen B; Sturgeon J
    Gynecol Oncol; 1994 Sep; 54(3):282-7. PubMed ID: 7522198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of single-agent chemotherapy regimens for gestational trophoblastic disease.
    Homesley HD
    J Reprod Med; 1994 Mar; 39(3):185-92. PubMed ID: 7518517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ten year's experience with methotrexate and folinic acid as primary therapy for gestational trophoblastic disease.
    Berkowitz RS; Goldstein DP; Bernstein MR
    Gynecol Oncol; 1986 Jan; 23(1):111-8. PubMed ID: 3002916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of high-risk gestational trophoblastic disease with methotrexate, actinomycin D, and cyclophosphamide chemotherapy.
    Lurain JR; Brewer JI
    Obstet Gynecol; 1985 Jun; 65(6):830-6. PubMed ID: 2987766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of multiagent chemotherapy and independent risk factors in the treatment of high-risk GTT--25 years experiences of KRI-TRD.
    Kim SJ; Bae SN; Kim JH; Kim CT; Han KT; Lee JM; Jung JK
    Int J Gynaecol Obstet; 1998 Apr; 60 Suppl 1():S85-96. PubMed ID: 9833620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methotrexate infusion and folinic acid in the primary therapy of nonmetastatic gestational trophoblastic tumors.
    Berkowitz RS; Goldstein DP; Bernstein MR
    Gynecol Oncol; 1990 Jan; 36(1):56-9. PubMed ID: 2153091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonmetastatic gestational trophoblastic disease. Weekly methotrexate compared with 8-day methotrexate-folinic acid.
    Gleeson NC; Finan MA; Fiorica JV; Robert WS; Hoffman MS; Wilson J
    Eur J Gynaecol Oncol; 1993; 14(6):461-5. PubMed ID: 7514124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy for gestational trophoblastic tumors.
    Takamizawa H; Sekiya S; Kobayashi O; Matsui H
    Semin Surg Oncol; 1987; 3(1):36-44. PubMed ID: 3027827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of chemotherapies with methotrexate, VP-16 and actinomycin-D in low-risk gestational trophoblastic disease. Remission rates and drug toxicities.
    Matsui H; Iitsuka Y; Seki K; Sekiya S
    Gynecol Obstet Invest; 1998; 46(1):5-8. PubMed ID: 9692333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy for trophoblastic disease: current standards.
    Kendall A; Gillmore R; Newlands E
    Curr Opin Obstet Gynecol; 2002 Feb; 14(1):33-8. PubMed ID: 11801874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poor-prognosis gestational trophoblastic disease: an update.
    Surwit EA; Alberts DS; Christian CD; Graham VE
    Obstet Gynecol; 1984 Jul; 64(1):21-6. PubMed ID: 6204257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of low-risk metastatic gestational trophoblastic tumors with single-agent chemotherapy.
    Roberts JP; Lurain JR
    Am J Obstet Gynecol; 1996 Jun; 174(6):1917-23; discussion 1923-4. PubMed ID: 8678159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gestational trophoblastic disease.
    Hammond CB; Olt GJ
    Curr Ther Endocrinol Metab; 1994; 5():567-70. PubMed ID: 7704794
    [No Abstract]   [Full Text] [Related]  

  • 19. Management of drug resistant gestational trophoblastic neoplasia.
    Patel SM; Desai A
    J Reprod Med; 2010; 55(7-8):296-300. PubMed ID: 20795341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methotrexate with citrovorum factor rescue: reduced chemotherapy toxicity in the management of gestational trophoblastic neoplasms.
    Berkowitz RS; Goldstein DP; Jones MA; Marean AR; Bernstein MR
    Cancer; 1980 Feb; 45(3):423-6. PubMed ID: 6243507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.